Business● Low17m ago · Nov 10, 2026, 6:02 PM
Liquidia plans PH-ILD enrollment completion in 2028 with L606 NDA submission target in 2029
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Liquidia plans to complete enrollment for its PH-ILD program in 2028. The company is targeting an NDA submission for its L606 drug in 2029.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business17m agoHesai expects Q4 revenue of RMB 1,100M to RMB 1,150M while targeting ~$100M SGI revenue in 2027Seeking Alpha TechBusiness17m agoScholar Rock anticipates CHMP opinion in H1 2027 as it monetizes a $205M priority review voucherSeeking Alpha TechBusiness22m agoCzechia to open CzechBusiness agency Office in LvivUkrinform [en]Business26m agoMicrosoft tumbles as Anthropic unveils office tools ahead of IPOSeeking Alpha Tech